Today's Daily Dose brings you news about Alder's stock offering; FDA panel recommendation of 2 biosimilar candidates; Sangamo's investigational drugs SB-318 and SB-913 getting Fast Track designation; Pfizer's upcoming regulatory catalyst related to its rheumatoid arthritis drug; Mallinckrodt's progress in its CONFIRM trial and MiMedx Group's better-than-expected Q2 revenue.
from RTT - Biotech http://ift.tt/2upiUrL
via IFTTT
No comments:
Post a Comment